Moon-Ju Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Moon-Ju Kim has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Wei Gao
Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA
4 shared publications - Jae-Chul Pyun
Department of Materials Science and Engineering, Yonsei University, Seoul, South Korea
3 shared publications - Min-Jung Kang
Korea Institute of Science and Technology
3 shared publications Canran Wang
Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, USA
2 shared publications- Gwangmook Kim
Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, USA
2 shared publications - Tae Gyeong Yun
Department of Materials Science and Engineering, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 14 November 2026
- Published by Wiley in Aging Cell
- Vol. 25 (11)
Resilience—A Concept Toward an Actionable Clinical Approach to Aging
Aging research has increasingly recognized the need for accurate biomarkers of aging, with aging clocks emerging as a powerful tool to quantify the degree of age‐related biological change. However, broad clinical implementation and the establishment of wide use of these biomarkers of aging remain ongoing. Resilience reflects a dynamic property of physiological homeostasis and offers a complementary lens to functionally interpret aging. Resilience does not capture the ground state the biological system is in, but rather its ability to maintain or improve function when challenged by adversity. Advances in wearable sensing technologies now enable scalable, continuous, and laboratory‐independent assessment of physiological, biochemical, and environmental parameters, which potentially offer a first window into resilience. Clinically, resilience holds promise for person‐centered risk stratification and guiding interventions, particularly in multimorbid populations. As such, we propose two lines of clinical resilience: first, reflecting involvement in disease onset mechanisms, and a second representing the capability to withstand and recover from medical interventions such as surgery or systemic pharmacotherapy. Integrating resilience into clinical frameworks may support personalized, proactive, and preventive approaches to aging, ultimately leading to meaningful clinical outcomes.
- 14 November 2026
- Published by Wiley in Aging Cell
- Vol. 25 (11)
Open AccessResilience—A Concept Toward an Actionable Clinical Approach to Aging
Aging research has increasingly recognized the need for accurate biomarkers of aging, with aging clocks emerging as a powerful tool to quantify the degree of age‐related biological change. However, broad clinical implementation and the establishment of wide use of these biomarkers of aging remain ongoing. Resilience reflects a dynamic property of physiological homeostasis and offers a complementary lens to functionally interpret aging. Resilience does not capture the ground state the biological system is in, but rather its ability to maintain or improve function when challenged by adversity. Advances in wearable sensing technologies now enable scalable, continuous, and laboratory‐independent assessment of physiological, biochemical, and environmental parameters, which potentially offer a first window into resilience. Clinically, resilience holds promise for person‐centered risk stratification and guiding interventions, particularly in multimorbid populations. As such, we propose two lines of clinical resilience: first, reflecting involvement in disease onset mechanisms, and a second representing the capability to withstand and recover from medical interventions such as surgery or systemic pharmacotherapy. Integrating resilience into clinical frameworks may support personalized, proactive, and preventive approaches to aging, ultimately leading to meaningful clinical outcomes.
- 29 July 2026
- Published by Springer Nature in Nature Nanotechnology
- Vol. 21 (10) , 1448-1458
Strain-isolated microneedles for ambulatory hormonal and metabolic monitoring
Hormones and metabolites jointly regulate physiology yet their dynamic interplay remains difficult to resolve due to the lack of technologies for continuous, multiplexed monitoring. Microneedle biosensors that access dermal interstitial fluid offer a minimally invasive approach to molecular profiling, but deployment is limited by trade-offs between fabrication scalability and precision, and by mechanical instability under skin deformation. Here we present a strain-isolated microneedle platform fabricated by combining two-photon polymerization with ultrasound-assisted moulding, enabling scalable replication of submicrometre-sharp microneedles (∼430-nm apex width) bearing hierarchical, high-surface-area microstructures. Nanostructured gold and platinum electrodes enable high-fidelity sensing at the single-needle level, providing a 4.7-fold higher peak current and a 9-fold larger electrochemical surface area, respectively. Mechanical decoupling of the sensing interface from tissue deformation preserves stable molecular access during motion. When integrated with battery-free wireless electronics and multiplexed aptameric and enzymatic sensors, the system enables continuous in vivo monitoring of serotonin and glucose for 12 h. In freely moving rats, the platform captures biomolecular dynamics associated with stress, feeding and circadian rhythms. This work establishes a mechanically robust, scalable microneedle biointerface for ambulatory molecular monitoring and context-aware assessment of physiological state.
- 29 July 2026
- Published by Springer Nature in Nature Nanotechnology
- Vol. 21 (10) , 1448-1458
Strain-isolated microneedles for ambulatory hormonal and metabolic monitoring
Hormones and metabolites jointly regulate physiology yet their dynamic interplay remains difficult to resolve due to the lack of technologies for continuous, multiplexed monitoring. Microneedle biosensors that access dermal interstitial fluid offer a minimally invasive approach to molecular profiling, but deployment is limited by trade-offs between fabrication scalability and precision, and by mechanical instability under skin deformation. Here we present a strain-isolated microneedle platform fabricated by combining two-photon polymerization with ultrasound-assisted moulding, enabling scalable replication of submicrometre-sharp microneedles (∼430-nm apex width) bearing hierarchical, high-surface-area microstructures. Nanostructured gold and platinum electrodes enable high-fidelity sensing at the single-needle level, providing a 4.7-fold higher peak current and a 9-fold larger electrochemical surface area, respectively. Mechanical decoupling of the sensing interface from tissue deformation preserves stable molecular access during motion. When integrated with battery-free wireless electronics and multiplexed aptameric and enzymatic sensors, the system enables continuous in vivo monitoring of serotonin and glucose for 12 h. In freely moving rats, the platform captures biomolecular dynamics associated with stress, feeding and circadian rhythms. This work establishes a mechanically robust, scalable microneedle biointerface for ambulatory molecular monitoring and context-aware assessment of physiological state.
- 16 March 2026
- Published by Springer Nature in Nature Sensors
- Vol. 1 (4) , 328-340
A battery-free smart mask for long-term exhaled breath biochemical sensing
- 16 March 2026
- Published by Springer Nature in Nature Sensors
- Vol. 1 (4) , 328-340
A battery-free smart mask for long-term exhaled breath biochemical sensing
- Top Cited Papers
- 12 March 2026
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (6) , 934-947
Biomolecular profiling for noninvasive health monitoring
Biomolecular profiling offers a powerful lens into human physiology, yet current diagnostics often rely on invasive sampling and delayed, centralized analysis. Advances in mass spectrometry (MS), particularly untargeted metabolomics and proteomics, have expanded molecular access to noninvasive biofluids such as sweat, saliva, tears and interstitial fluid, revealing dynamic biomarkers linked to both chronic and acute conditions. In parallel, wearable biosensors enable real-time, on-body chemical sensing, but remain limited to a narrow panel of predefined analytes. This Review highlights how MS-based molecular discovery and wearable sensing serve as complementary approaches—MS enabling high-dimensional untargeted profiling and wearables delivering longitudinal real-time data—and also discusses how their bidirectional integration and co-evolution open new possibilities for personalized noninvasive health monitoring. We discuss advances in sampling strategies, sensing modalities and system integration, and outline criteria for identifying biomarkers amenable to sensor translation. By uniting untargeted discovery with real-world deployment, this convergence shifts personalized noninvasive healthcare from episodic diagnostics to continuous, context-aware monitoring.
- 12 March 2026
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (6) , 934-947
Top Cited PapersBiomolecular profiling for noninvasive health monitoring
Biomolecular profiling offers a powerful lens into human physiology, yet current diagnostics often rely on invasive sampling and delayed, centralized analysis. Advances in mass spectrometry (MS), particularly untargeted metabolomics and proteomics, have expanded molecular access to noninvasive biofluids such as sweat, saliva, tears and interstitial fluid, revealing dynamic biomarkers linked to both chronic and acute conditions. In parallel, wearable biosensors enable real-time, on-body chemical sensing, but remain limited to a narrow panel of predefined analytes. This Review highlights how MS-based molecular discovery and wearable sensing serve as complementary approaches—MS enabling high-dimensional untargeted profiling and wearables delivering longitudinal real-time data—and also discusses how their bidirectional integration and co-evolution open new possibilities for personalized noninvasive health monitoring. We discuss advances in sampling strategies, sensing modalities and system integration, and outline criteria for identifying biomarkers amenable to sensor translation. By uniting untargeted discovery with real-world deployment, this convergence shifts personalized noninvasive healthcare from episodic diagnostics to continuous, context-aware monitoring.
- 14 August 2023
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 238, 115598
Phage-targeting bimetallic nanoplasmonic biochip functionalized with bacterial outer membranes as a biorecognition element
- 14 August 2023
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 238, 115598
Phage-targeting bimetallic nanoplasmonic biochip functionalized with bacterial outer membranes as a biorecognition element
- 18 July 2023
- Published by Elsevier in Materials Today Communications
- Vol. 36
Parylene-coated SiO2 aerogel with controlled thermal conductivity
- 18 July 2023
- Published by Elsevier in Materials Today Communications
- Vol. 36
Parylene-coated SiO2 aerogel with controlled thermal conductivity
- 23 September 2022
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 147 (22) , 5044-5053
Simultaneous analysis of acylcarnitines using MALDI-TOF mass spectrometry based on a parylene matrix chip
Short and medium chain acylcarnitines have been used for the diagnosis of various fatty acid oxidation and organic acid disorders. This report presents a multiplex and quantitative analysis of acylcarnitines using MALDI-TOF MS based on a parylene matrix chip. The parylene matrix chip was fabricated by the deposition of a nanoporous film of parylene on an organic matrix array, which reduced the number of mass peaks from the organic matrix in the low m/z range. Quantitative analysis was possible using the parylene matrix chip because of the formation of nano-sized sample crystals on the nanoporous parylene film. Seven acylcarnitines were quantitatively analyzed using the chip; the method detection range included the cut-off values for metabolic disorders. The seven acylcarnitines of different concentrations were simultaneously detected using the parylene matrix chip and the interference from the mixed carnitines was estimated. Real L-carnitine (C0) samples were analyzed using serial dilution, and the recoveries were calculated by comparisons with a standard curve.
- 23 September 2022
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 147 (22) , 5044-5053
Simultaneous analysis of acylcarnitines using MALDI-TOF mass spectrometry based on a parylene matrix chip
Short and medium chain acylcarnitines have been used for the diagnosis of various fatty acid oxidation and organic acid disorders. This report presents a multiplex and quantitative analysis of acylcarnitines using MALDI-TOF MS based on a parylene matrix chip. The parylene matrix chip was fabricated by the deposition of a nanoporous film of parylene on an organic matrix array, which reduced the number of mass peaks from the organic matrix in the low m/z range. Quantitative analysis was possible using the parylene matrix chip because of the formation of nano-sized sample crystals on the nanoporous parylene film. Seven acylcarnitines were quantitatively analyzed using the chip; the method detection range included the cut-off values for metabolic disorders. The seven acylcarnitines of different concentrations were simultaneously detected using the parylene matrix chip and the interference from the mixed carnitines was estimated. Real L-carnitine (C0) samples were analyzed using serial dilution, and the recoveries were calculated by comparisons with a standard curve.